CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-18 | Powell Lynne Senior VP - CCO | Sale | −2,000 | $9.40 | $19K | 0 |
| 2019-01-18 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −2,000 | 91,427 | ||
| 2019-01-16 | Powell Lynne Senior VP - CCO | Option exercise | +3,046 | $3.22 | $10K | 3,046 |
| 2019-01-16 | Powell Lynne Senior VP - CCO | Sale | −3,046 | $9.27 | $28K | 0 |
| 2019-01-16 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −3,046 | 93,427 | ||
| 2019-01-14 | Powell Lynne Senior VP - CCO | Option exercise | +954 | $3.22 | $3K | 954 |
| 2019-01-14 | Powell Lynne Senior VP - CCO | Sale | −954 | $9.20 | $9K | 0 |
| 2019-01-14 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −954 | 96,473 | ||
| 2019-01-04 | ASELAGE STEVE Director | Grant or award · Non-Qualified Stock Option | +25,000 | 25,000 | ||
| 2019-01-01 | Barnes Alane P Senior VP, Chief Legal Officer | Shares withheld for taxes | −423 | $8.07 | $3K | 77,530 |
| 2019-01-01 | Babu Yarlagadda S Senior VP - Drug Discovery | Shares withheld for taxes | −771 | $8.07 | $6K | 108,100 |
| 2019-01-01 | Sheridan William P Senior VP - CMO | Shares withheld for taxes | −1,087 | $8.07 | $9K | 1,638 |
| 2019-01-01 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −785 | $8.07 | $6K | 132,676 |
| 2019-01-01 | Stonehouse Jon P President & CEO | Shares withheld for taxes | −3,568 | $8.07 | $29K | 724,106 |
| 2018-12-20 | Barnes Alane P Senior VP, Chief Legal Officer | Grant or award · Emp. Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2018-12-20 | Powell Lynne Senior VP - CCO | Grant or award · Emp. Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2018-12-20 | Babu Yarlagadda S Senior VP - Drug Discovery | Grant or award · Emp. Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2018-12-20 | Sheridan William P Senior VP - CMO | Grant or award · Emp. Stock Option (Right to Buy) | +335,000 | 335,000 | ||
| 2018-12-20 | STAAB THOMAS R II Senior Vice President and CFO | Grant or award · Emp. Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2018-12-20 | Stonehouse Jon P President & CEO | Grant or award · Emp. Stock Option (Right to Buy) | +675,000 | 675,000 |
Page 31 of 38 · 750 trades